This content is not available in your region

Pfizer in talks over full license for COVID-19 vaccine in Singapore

Access to the comments Comments
By Reuters
Pfizer in talks over full license for COVID-19 vaccine in Singapore
Pfizer in talks over full license for COVID-19 vaccine in Singapore   -   Copyright  Thomson Reuters 2021   -  

<div> <p><span class="caps">SINGAPORE</span> – Pfizer Inc is in discussions with Singapore’s Health Sciences Authority regarding obtaining a full license application for its <span class="caps">COVID</span>-19 vaccine, the company said in response to a query from Reuters. </p> <p>Pfizer-BioNTech’s <span class="caps">COVID</span>-19 vaccine has interim authorisation under the pandemic special access route in Singapore. The U.S. Food and Drug Administration granted full approval to the vaccine last month.</p> <p>Kenneth Mak, Singapore’s director of medical services, said in a briefing on Friday Pfizer and Moderna had not submitted applications for full registration to authorities.</p> <p>Singapore has not made <span class="caps">COVID</span>-19 vaccination compulsory, saying the Pfizer and Moderna shots only have emergency approval, although it has limited activities such as eating out for the unvaccinated.</p> <p>Some experts say full registration could pave the way https://www.reuters.com/business/healthcare-pharmaceuticals/calls-grow-among-experts-singapore-vaccine-mandate-covid-19-spikes-2021-09-21 to make vaccination mandatory.</p> <p/> </div>